Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck
- 15 August 2001
- Vol. 92 (4) , 814-821
- https://doi.org/10.1002/1097-0142(20010815)92:4<814::aid-cncr1387>3.0.co;2-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Suppression of Retinoic Acid Receptor–β in Premalignant Oral Lesions and Its Up-Regulation by IsotretinoinNew England Journal of Medicine, 1995
- Ifosfamide and Mesna for the Treatment of Advanced Squamous Cell Head and Neck CancerOncology, 1991
- Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 1990
- Inhibition of growth and squamous‐cell differentiation markers in cultured human head and neck squamous carcinoma cells by β‐all‐trans retinoic acidInternational Journal of Cancer, 1990
- IfosamideJNCI Journal of the National Cancer Institute, 1988
- Ifosfamide in advanced head and neck cancer. A phase II study of the Rotterdam cooperative head and neck cancer study groupEuropean Journal of Cancer and Clinical Oncology, 1988
- Chemotherapy in Head and Neck CancerNew England Journal of Medicine, 1983
- The induction of differentiation in teratocarcinoma stem cells by retinoic acidCell, 1978
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958